Revenue, last quarter
$8M
+46% vs same quarter last year
Net income
$952.5K
+781.6% vs same quarter last year
EPS, diluted
$0.10
+600% vs same quarter last year
Operating cash flow
$755.9K
+163.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $27.6M | −$1M |
| FY24 | $26.5M | −$2.2M |
| FY23 | $17.5M | −$5.8M |
| FY22 | $18.6M | −$2.5M |
| FY21 | $19.2M | −$78.3K |
| FY20 | $15.3M | −$1M |
| FY19 | $13.7M | −$1.3M |
| FY18 | $11M | −$2.3M |
| FY17 | $10.4M | −$168.1K |
| FY16 | $9.5M | $508.4K |
| FY15 | $10.2M | $1.2M |
| FY14 | $7.6M | −$167.2K |
| FY13 | $6M | $117.4K |
| FY12 | $5.4M | $89.5K |
| FY11 | $5.1M | −$409.5K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 41.4% | 6% | −3.8% |
| FY24 | 30% | −6.2% | −8.1% |
| FY23 | 22.1% | −32.9% | −33.1% |
| FY22 | 41.2% | −12.4% | −13.4% |
| FY21 | 45% | 1.3% | −0.4% |
| FY20 | 44.7% | −9% | −6.7% |
| FY19 | 49.1% | −7% | −9.4% |
| FY18 | 47.3% | −13.2% | −21.1% |
| FY17 | 50.1% | −2.3% | −1.6% |
| FY16 | 56.8% | 9.3% | 5.3% |
| FY15 | 61.1% | 20.7% | 11.9% |
| FY14 | 58.6% | −2.7% | −2.2% |
| FY13 | 50.9% | −0.3% | 2% |
| FY12 | 56.7% | 4.5% | 1.7% |
| FY11 | 55.1% | −12.4% | −8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.2M |
| FY24 | −$107.8K |
| FY23 | −$6.6M |
| FY22 | −$5.5M |
| FY21 | −$1.7M |
| FY20 | −$2.8M |
| FY19 | −$1.2M |
| FY18 | −$2.4M |
| FY17 | −$16.6M |
| FY16 | −$3.8M |
| FY15 | $181K |
| FY14 | −$1.2M |
| FY13 | $501K |
| FY12 | $69K |
| FY11 | −$281.1K |
- Immucell
- Healthcare median
Show the numbers
| Year | Immucell | Healthcare median |
|---|---|---|
| FY25 | −3.8% | −30.6% |
| FY24 | −8.1% | −47% |
| FY23 | −33.1% | −58% |
| FY22 | −13.4% | −80.4% |
| FY21 | −0.4% | −71.8% |
| FY20 | −6.7% | −62.2% |
| FY19 | −9.4% | −46.2% |
| FY18 | −21.1% | −49.6% |
| FY17 | −1.6% | −45.9% |
| FY16 | 5.3% | −36% |
| FY15 | 11.9% | −37.8% |
| FY14 | −2.2% | −35.5% |
| FY13 | 2% | −37.1% |
| FY12 | 1.7% | −29.1% |
| FY11 | −8% | −27.9% |